FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.24  |  FHIR Version n/a  User: [n/a]

37511611000001103: Incruse Ellipta 55micrograms/dose dry powder inhaler (Mawdsley-Brooks & Company Ltd) 30 dose (product)

Status: current, Not sufficiently defined by necessary conditions definition status. Date: 07-Aug 2019. Module: SNOMED CT United Kingdom drug extension module

Descriptions:

Id Description Lang Type Status Case? Module
354241000001114 Incruse Ellipta 55micrograms/dose dry powder inhaler (Mawdsley-Brooks & Company Ltd) 30 dose en Synonym Active Entire term case sensitive SNOMED CT United Kingdom drug extension module
354251000001112 Incruse Ellipta 55micrograms/dose dry powder inhaler (Mawdsley-Brooks & Company Ltd) 30 dose (product) en Fully specified name Active Entire term case sensitive SNOMED CT United Kingdom drug extension module

0 descendants.

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
Incruse Ellipta 55micrograms/dose dry powder inhaler (Mawdsley-Brooks & Company Ltd) 30 dose Discontinued indicator Never discontinued false Inferred relationship Existential restriction modifier
Incruse Ellipta 55micrograms/dose dry powder inhaler (Mawdsley-Brooks & Company Ltd) 30 dose Legal category Prescription only medicine - legal category (qualifier value) true Inferred relationship Existential restriction modifier
Incruse Ellipta 55micrograms/dose dry powder inhaler (Mawdsley-Brooks & Company Ltd) 30 dose Is a Umeclidinium bromide 65micrograms/dose dry powder inhaler 30 dose true Inferred relationship Existential restriction modifier
Incruse Ellipta 55micrograms/dose dry powder inhaler (Mawdsley-Brooks & Company Ltd) 30 dose Is a Actual medicinal product pack true Inferred relationship Existential restriction modifier
Incruse Ellipta 55micrograms/dose dry powder inhaler (Mawdsley-Brooks & Company Ltd) 30 dose Has AMP Incruse Ellipta 55micrograms/dose dry powder inhaler (Mawdsley-Brooks & Company Ltd) true Inferred relationship Existential restriction modifier
Incruse Ellipta 55micrograms/dose dry powder inhaler (Mawdsley-Brooks & Company Ltd) 30 dose VMP non-availability indicator Available true Inferred relationship Existential restriction modifier
Incruse Ellipta 55micrograms/dose dry powder inhaler (Mawdsley-Brooks & Company Ltd) 30 dose VMP prescribing status (attribute) VMP valid as a prescribable product true Inferred relationship Existential restriction modifier
Incruse Ellipta 55micrograms/dose dry powder inhaler (Mawdsley-Brooks & Company Ltd) 30 dose Has excipient Excipient not declared true Inferred relationship Existential restriction modifier
Incruse Ellipta 55micrograms/dose dry powder inhaler (Mawdsley-Brooks & Company Ltd) 30 dose Has specific active ingredient Umeclidinium bromide true Inferred relationship Existential restriction modifier
Incruse Ellipta 55micrograms/dose dry powder inhaler (Mawdsley-Brooks & Company Ltd) 30 dose Has NHS dm+d (dictionary of medicines and devices) controlled drug category Controlled drug category No Controlled Drug Status true Inferred relationship Existential restriction modifier
Incruse Ellipta 55micrograms/dose dry powder inhaler (Mawdsley-Brooks & Company Ltd) 30 dose Has dispensed dose form Conventional release powder for inhalation true Inferred relationship Existential restriction modifier
Incruse Ellipta 55micrograms/dose dry powder inhaler (Mawdsley-Brooks & Company Ltd) 30 dose Has NHS dm+d (dictionary of medicines and devices) additional monitoring indicator EMA (European Medicines Agency) monitoring true Inferred relationship Existential restriction modifier
Incruse Ellipta 55micrograms/dose dry powder inhaler (Mawdsley-Brooks & Company Ltd) 30 dose Has NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction indicator NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction none true Inferred relationship Existential restriction modifier
Incruse Ellipta 55micrograms/dose dry powder inhaler (Mawdsley-Brooks & Company Ltd) 30 dose Has NHS dm+d (dictionary of medicines and devices) parallel import indicator Parallel import true Inferred relationship Existential restriction modifier
Incruse Ellipta 55micrograms/dose dry powder inhaler (Mawdsley-Brooks & Company Ltd) 30 dose Discontinued indicator Discontinued AMPP(qualifier value) true Inferred relationship Existential restriction modifier
Inbound Relationships Type Active Source Characteristic Refinability Group

This concept is not in any reference sets

Back to Start